CDX: CardieX receives FDA 510(k) Clearance for CONNEQT Pulse
CARDIEX LIMITED
- CardieX receives FDA 510(k) clearance for the CONNEQT Pulse, a first-of-its-kind multi-use vascular biometric monitor.
- The Pulse measures both brachial and central blood pressure, arterial waveform analysis, and other unique vascular biomarkers – targeting home health, remote patient monitoring, and decentralized clinical trial markets.
- Commercial availability of the Pulse is expected in Q3 of this year, addressing new and significant global markets for cardiovascular health monitoring and vascular disease management.
2023-04-26 10:03:00